New Blood announces two dates at once
While the date for one game is moving back a few weeks, another is sliding in to take its place. Publisher New Blood confirms that Gloomwood will have its Early Access launch pushed back, with Ultrakill Act 2 taking its spot.
While the immersive sim Gloomwood was set to hit Early Access on August 16, the game will need some extra time to come together. A few issues have cropped up over the last few months, according to a statement, as well as some developers coming down with COVID-19. The team made the decision to push its release date back by three weeks, to September 6.
We have made the decision to delay the Early Access launch of Gloomwood (but only by 3 short weeks) to September 6th.https://t.co/AYYCrfnoOm
But fear not, for in its place on August 16th comes…
ACT 2 of ULTRAKILLhttps://t.co/J6RbJysU2y pic.twitter.com/sDPknYVC1h
— New Blood Interactive (@NewBlood) August 2, 2022
It’s a little extra time for those who have been patiently waiting, but from the ash arrives a new launch to take its place. New Blood confirms that the second act of Ultrakill, a retro-inspired FPS inspired by the heydays of the ’90s, arrives on August 16.
Ultrakill, which is in Early Access right now, has an overwhelmingly positive reception so far on Steam’s user reviews. And while it’s only $20 at the moment, the price will be going up on August 16 with the launch of Act 2.
Hot swap launches
While Gloomwood fans may be waiting a bit longer for their particular brand of immersive sim, there is at least more Ultrakill on the way to tide them over. And really, both seem to scratch an itch of retro-inspired first-person PC gaming. Just each in their own little way; Gloomwood in sneaking and surviving, and Ultrakill in over-the-top shooter fashion.
It’s a fun swap that New Blood has done, and I’m down with it. Plus, Gloomwood also has a pre-alpha demo available on its Steam page right now, if you’re quite eager to try it out. Ultrakill also has a demo, and Act 1 is currently in Early Access.
Published: Aug 2, 2022 05:00 pm